{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:07:25Z","timestamp":1768421245935,"version":"3.49.0"},"reference-count":52,"publisher":"BMJ","issue":"9","funder":[{"name":"the Clinical capacity-building project of Liaoning Province in China","award":["LNCCC-B05-2014"],"award-info":[{"award-number":["LNCCC-B05-2014"]}]},{"name":"the Open fund of Key Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine","award":["No.ZYZX1501"],"award-info":[{"award-number":["No.ZYZX1501"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,8,20]]},"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Achieving efficacious and safe treatments for unstable angina pectoris (UAP) is still a challenging clinical problem. The availability of different oral Chinese patent medicines frequently poses a practical challenge to clinicians, namely, which one to choose as first-line regimen for treatment. This study aims to examine the comparative effectiveness and safety of oral Chinese patent medicines for UAP on the national essential drugs list of China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will conduct a network meta-analysis (NMA) of all randomised controlled trials to evaluate the use of oral Chinese patent medicines as adjuvant for the treatment of UAP. We will explore eight electronic databases from their inception to June 2018 and search for grey literature. Primary outcomes include mortality and the cardiovascular events. Secondary outcomes include: (1) symptom improvement; (2) ECG improvement; (3) frequency of acute angina attack; (4) duration of angina; (5) adverse effects. Two independent authors will screen titles and abstracts, review full texts, extract data, assess the risk of bias using the Cochrane risk of bias tool and assess the quality of evidence and strength of the recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE). If adequate data are available, NMA will be performed with Bayesian analysis methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The NMA will help us to reduce the uncertainty of interventions and help clinicians to make optimal and more accurate therapeutic decisions for adults with UAP. Therefore, we will publish the findings of this study in a peer-reviewed journal. No ethics approval is necessary for this study based on the nature of its design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>CRD42018092822.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-026136","type":"journal-article","created":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T07:05:11Z","timestamp":1569049511000},"page":"e026136","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness and safety of oral Chinese patent medicines as adjuvant treatment for unstable angina pectoris on the national essential drugs list of China: a protocol for a systematic review and network meta-analysis"],"prefix":"10.1136","volume":"9","author":[{"given":"Zhen","family":"Hua","sequence":"first","affiliation":[{"name":"Shandong Provincial Qianfoshan Hospital, The First Hospital Affiliated with Shandong First Medical University, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Ting","family":"Zhai","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhui","family":"Tian","sequence":"additional","affiliation":[{"name":"Evidence-based Medicine Center of Lanzhou University, Lanzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1409-7662","authenticated-orcid":false,"given":"Cheng-Fei","family":"Gao","sequence":"additional","affiliation":[{"name":"Center of Rehabilitation Medicine, Sichuan University, Chengdu, China"},{"name":"Biomedical Engineering, Hong Kong Polytechnic University, Kowloon, Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Traditional Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-jia","family":"Liu","sequence":"additional","affiliation":[{"name":"Liaoning Traditional Chinese Medicine of Jiahe, Shenyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Dong","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine, Shenyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Feng","family":"Du","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine, Shenyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China"},{"name":"Key Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanlin","family":"Yang","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine, Shenyang, China"},{"name":"Key Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"key":"2025121513233315000_9.9.e026136.1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.1.613"},{"key":"2025121513233315000_9.9.e026136.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000558"},{"key":"2025121513233315000_9.9.e026136.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000485"},{"key":"2025121513233315000_9.9.e026136.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000350"},{"key":"2025121513233315000_9.9.e026136.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1216063"},{"key":"2025121513233315000_9.9.e026136.6","first-page":"60","article-title":"Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease","volume":"1","author":"Badimon","year":"2012","journal-title":"Eur Heart J"},{"key":"2025121513233315000_9.9.e026136.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071014"},{"key":"2025121513233315000_9.9.e026136.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000134"},{"key":"2025121513233315000_9.9.e026136.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv320"},{"key":"2025121513233315000_9.9.e026136.10","first-page":"359","article-title":"Chinese Society of cardiology, editorial board of Chinese Journal of cardiovascular. guidelines for diagnosis and treatment of non-ST-segment elevation acute coronary syndromes (2016)","volume":"5","year":"2017","journal-title":"Chin J Cardiol"},{"key":"2025121513233315000_9.9.e026136.11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jjcc.2014.11.003","article-title":"Guideline-adherence and perspectives in the acute management of unstable angina - Initial results from the German chest pain unit registry","volume":"66","author":"Breuckmann","year":"2015","journal-title":"J Cardiol"},{"key":"2025121513233315000_9.9.e026136.12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/VHRM.S119490","article-title":"High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor study","volume":"13","author":"Goss","year":"2017","journal-title":"Vasc Health Risk Manag"},{"key":"2025121513233315000_9.9.e026136.13","first-page":"25","article-title":"Tailor treatment to the patient in stable angina","volume":"255","author":"Taggart","year":"2011","journal-title":"Practitioner"},{"key":"2025121513233315000_9.9.e026136.14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1017\/S106279870300022X","article-title":"The integration of traditional Chinese medicine and Western medicine","volume":"11","author":"Chen","year":"2003","journal-title":"European Rev"},{"key":"2025121513233315000_9.9.e026136.15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1142\/S0192415X12500188","article-title":"Comprehension of the unique characteristics of traditional Chinese medicine","volume":"40","author":"Xutian","year":"2012","journal-title":"Am J Chin Med"},{"key":"2025121513233315000_9.9.e026136.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.04.041"},{"key":"2025121513233315000_9.9.e026136.17","first-page":"42","article-title":"Trends in use of complementary and alternative medicine by US adults: 1997-2002","volume":"11","author":"Tindle","year":"2005","journal-title":"Altern Ther Health Med"},{"key":"2025121513233315000_9.9.e026136.18","unstructured":"Claxton M . Culture, health and civilization. In: Leander B , ed. Culture and health. Paris: UNESCO Pub, 1996: 17\u201346."},{"key":"2025121513233315000_9.9.e026136.19","unstructured":"National Health Commission of the People's Republic of China . The National essential drugs list of China (2018 edition). Beijing: People's Medical Publishing House, 2018."},{"key":"2025121513233315000_9.9.e026136.20","unstructured":"Li S . The Use of Suxiaojiuxinwan in Southeast Asia (Golden Triangle Area) - A Glimpse. Chinese Traditional Patent Medicine 1995;17."},{"key":"2025121513233315000_9.9.e026136.21","unstructured":"Sung HJ , Shin HK . Comparision and research on policy of traditional medicine in Korea and three countries of East Asia. Korean: Korean Institute of Oriental Medicine, 1997."},{"key":"2025121513233315000_9.9.e026136.22","unstructured":"World Health Organization . WTO traditional medicine strategy 2002-2005. World Health Organization, 2002."},{"key":"2025121513233315000_9.9.e026136.23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ctim.2014.01.003","article-title":"Chinese patent medicine Xuefu Zhuyu capsule for the treatment of unstable angina pectoris: a systematic review of randomized controlled trials","volume":"22","author":"Yang","year":"2014","journal-title":"Complement Ther Med"},{"key":"2025121513233315000_9.9.e026136.24","doi-asserted-by":"crossref","unstructured":"Wu T , Harrison RA , Chen XY , et al . Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris. Cochrane Database Syst Rev 2006;13.doi:10.1002\/14651858.CD004474.pub2","DOI":"10.1002\/14651858.CD004474.pub2"},{"key":"2025121513233315000_9.9.e026136.25","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/403251"},{"key":"2025121513233315000_9.9.e026136.26","unstructured":"Zoccai GB . Network meta-analysis: evidence synthesis with mixed treatment comparison. New York: Nova Science Publishers Inc, 2014."},{"key":"2025121513233315000_9.9.e026136.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2025121513233315000_9.9.e026136.28","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"2025121513233315000_9.9.e026136.29","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.59.3.607"},{"key":"2025121513233315000_9.9.e026136.30","first-page":"8","article-title":"Diagnosis and treatment of unstable angina pectoris","volume":"06","year":"2000","journal-title":"Chin J Cardiol"},{"key":"2025121513233315000_9.9.e026136.31","first-page":"295","article-title":"Editorial Committee of Chinese Journal of Cardiology. Unstable angina and non-ST segment elevation myocardial infarction diagnosis and treatment guidelines","volume":"35","year":"2007","journal-title":"Chin J Cardiol"},{"key":"2025121513233315000_9.9.e026136.32","unstructured":"Ge J , Xu Y . Internal medicine. 8th edn. Beijing: People's Medical Publishing House, 2014."},{"key":"2025121513233315000_9.9.e026136.33","first-page":"17","article-title":"Symposium on treatment of angina pectoris and arrhythmia of coronary heart disease with integrated traditional Chinese and Western medicine. Coronary heart disease, angina pectoris and electrocardiogram evaluation criteria (1979, Shanghai)","volume":"02","year":"1987","journal-title":"Chinese Pharmaceutical Affairs"},{"key":"2025121513233315000_9.9.e026136.34","unstructured":"Corp A . Introdution of NoteExpress, 2018. Available: http:\/\/www.inoteexpress.com\/index.htm"},{"key":"2025121513233315000_9.9.e026136.35","unstructured":"Higgins JPT , Green S . Cochrane Handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane collaboration, 2011. Available: http:\/\/www.handbook.cochrane.org\/"},{"key":"2025121513233315000_9.9.e026136.36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025121513233315000_9.9.e026136.37","unstructured":"Higgins JPT , Altman DG . Chapter 9: Analysing data and undertaking meta-analyses. In: Deeks JJ , Higgins JPT , eds. Cochrane Handbook for systematic reviews of interventions. Chichester, UK: John Wiley & Sons, 2011."},{"key":"2025121513233315000_9.9.e026136.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2012.01.033"},{"key":"2025121513233315000_9.9.e026136.39","first-page":"972","article-title":"Treatment methods of traditional Chinese medicine for unstable angina of coronary heart disease","volume":"39","author":"Tian","year":"2019","journal-title":"Jilin Journal of Chinese Medicine"},{"key":"2025121513233315000_9.9.e026136.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f2914","article-title":"Demystifying trial networks and network meta-analysis","volume":"346","author":"Mills","year":"2013","journal-title":"BMJ"},{"key":"2025121513233315000_9.9.e026136.41","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-2994-2"},{"key":"2025121513233315000_9.9.e026136.42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"2025121513233315000_9.9.e026136.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"2025121513233315000_9.9.e026136.44","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1045"},{"key":"2025121513233315000_9.9.e026136.45","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-106","article-title":"Characteristics of a loop of evidence that affect detection and estimation of inconsistency: a simulation study","volume":"14","author":"Veroniki","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2025121513233315000_9.9.e026136.46","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys222"},{"key":"2025121513233315000_9.9.e026136.47","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4909","article-title":"Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study","volume":"343","author":"Song","year":"2011","journal-title":"BMJ"},{"key":"2025121513233315000_9.9.e026136.48","unstructured":"Higgins JPT , Altman DG , Higgins JPT , et al . Chapter 8: Assessing risk of bias in included studies. In: Cochrane Handbook for systematic reviews of interventions. Chichester, UK: John Wiley & Sons, 2011."},{"key":"2025121513233315000_9.9.e026136.49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"2025121513233315000_9.9.e026136.50","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008929526011"},{"key":"2025121513233315000_9.9.e026136.51","doi-asserted-by":"crossref","unstructured":"Schwarzer G . Network meta-analysis. In: Schwarzer G , Carpenter JR , R\u00fccker G , eds. Meta-analysis with R. Berlin. Heidelberg: Springer, 2015: 187\u2013216.","DOI":"10.1007\/978-3-319-21416-0_8"},{"key":"2025121513233315000_9.9.e026136.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-026136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T21:23:41Z","timestamp":1765833821000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-026136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":52,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,20]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1136\/bmjopen-2018-026136"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-026136","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}